Biora Therapeutics, Inc. - SIC # 8010 -

Ticker Exchange SIC # Website Latest Ticker
BIOR Nasdaq 8010 www.bioratherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biora Therapeutics, Inc.

Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - Nov 14th, 2024 1:00 pm
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update - Nov 7th, 2024 9:30 pm
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Oct 29th, 2024 12:00 pm
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting - Oct 28th, 2024 12:00 pm
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting - Oct 14th, 2024 12:00 pm
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium - Oct 7th, 2024 12:00 pm
Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024 - Sep 30th, 2024 12:00 pm
Biora Therapeutics Achieves ISO 13485 Certification - Sep 9th, 2024 12:00 pm
Biora Therapeutics Announces Positive Nasdaq Listing Decision - Aug 28th, 2024 12:00 pm
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - Aug 26th, 2024 12:00 pm
BIOR: Second Quarter Results - Aug 15th, 2024 3:15 pm
Biora Therapeutics Second Quarter 2024 Earnings: EPS: US$0.18 (vs US$1.47 loss in 2Q 2023) - Aug 14th, 2024 12:14 pm
Q2 2024 Biora Therapeutics Inc Earnings Call - Aug 13th, 2024 6:01 pm
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results - Aug 12th, 2024 8:15 pm
Biora Therapeutics Announces Funding Agreement with Existing Investors - Aug 12th, 2024 8:05 pm
Biora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate Update - Aug 8th, 2024 8:30 pm
Biora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference - Aug 6th, 2024 12:00 pm
Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event - Jul 18th, 2024 12:00 pm
Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024 - Jul 8th, 2024 12:00 pm
BIOR: BT-600 Topline - Jul 8th, 2024 9:30 am